Introduction
============

Nasopharyngeal carcinoma (NPC) is a cancer that is distinct from other epithelial tumors of the head and neck region ([@b1-or-0-0-7392]). NPC has a peculiar geographical distribution, and its incidence is higher in Southern China and South-Central Asia, representing the most frequent carcinoma of the head and neck region in these geographical regions ([@b1-or-0-0-7392],[@b2-or-0-0-7392]). Efficient imaging techniques are crucial for staging and planning the correct radiotherapy treatment for patients with NPC ([@b1-or-0-0-7392]). Integrated positron emission tomography-computed tomography (PET/CT) using fluorine-18 fludeoxyglucose (^18^F-FDG), which provides metabolic parameters such as the standardized uptake value (SUV) and total lesion glycolysis, is a widely used techniques in cancer staging assessment and for predicting clinical outcomes ([@b3-or-0-0-7392],[@b4-or-0-0-7392]). PET/CT is sensitive and accurate for the detection of nodal metastases and distant metastases, but lacks the soft tissue resolution compared to the magnetic resonance imaging (MRI) when analyzing primary tumor ([@b5-or-0-0-7392]--[@b7-or-0-0-7392]). Similarly, MRI provides a higher resolution than CT in terms of assessing parapharyngeal spaces, marrow infiltration of the skull base, intracranial disease and deep cervical nodes in NPC ([@b1-or-0-0-7392]). Additionally, the development of the MRI technology, including diffusion and perfusion MRI, has added the potential to analyze biological features in addition to the structural analysis ([@b1-or-0-0-7392]).

PET and MR both provide functional parameters: Cellular glucose metabolism as expressed by SUV can be identified by PET, and the random Brownian motion of water molecules expressed by the apparent diffusion coefficient (ADC) can be analyzed by MRI ([@b8-or-0-0-7392]). Many malignant tumors show a significantly increased glucose uptake, and malignant tumor with high cellularity exhibit higher diffusions restrictions, which are indicated by a low ADC ([@b9-or-0-0-7392]--[@b14-or-0-0-7392]). Therefore, based on the hypothesis that SUV and ADC provide similar information about tumors and show a negative correlation, many previous studies reported the correlation between SUV and ADC for various tumors, but the results are not homogenous ([@b8-or-0-0-7392]--[@b19-or-0-0-7392]). An inverse correlation was demonstrated in non-small cell lung cancer ([@b9-or-0-0-7392]), breast cancer ([@b10-or-0-0-7392]--[@b12-or-0-0-7392]), gastrointestinal stromal tumor ([@b13-or-0-0-7392]) and cervical cancer ([@b14-or-0-0-7392]). However, data from patients with lymphoma suggested that SUV and ADC are independent biomarkers ([@b15-or-0-0-7392],[@b16-or-0-0-7392]). For head and neck squamous cell carcinoma (HNSCC), it is unclear whether there is a significant correlation between SUV and ADC ([@b8-or-0-0-7392],[@b17-or-0-0-7392]--[@b19-or-0-0-7392]).

The movement of water molecules contributing to the signal in diffusion-weighted imaging (DWI) are caused by different factors: Extracellular space diffusion, intracellular space diffusion and intravascular space diffusion (or perfusion) ([@b20-or-0-0-7392]--[@b22-or-0-0-7392]). Accordingly, the signal attenuation on conventional mono-exponential DWI does not always present a linear relationship, and it is difficult to calculate an accurate ADC value ([@b23-or-0-0-7392]). In order to separate the motion of water molecules due to perfusion in the microcirculation from that due to diffusion in the extravascular space, the intravoxel incoherent motion (IVIM) imaging method, first described by Le *et al* ([@b22-or-0-0-7392]) may be used. IVIM is a powerful imaging technique that uses DWI with multiple b values followed by bi-exponential curve fitting. IVIM can provide the true diffusion coefficient (D), the pseudo-diffusion coefficient or diffusion within the microcirculation (D\*), and the perfusion fraction or the contribution of water moving in the capillaries (f). Several studies have reported the application of IVIM in NPC, and these previous reports have shown that IVIM is a feasible technique ([@b24-or-0-0-7392],[@b25-or-0-0-7392]). In addition, IVIM parameters have been associated with clinical stage ([@b26-or-0-0-7392]) and dynamic contrast enhanced-MRI parameters ([@b25-or-0-0-7392]). IVIM can be applied to differentiating lymphoma ([@b27-or-0-0-7392]) and enlarged adenoids ([@b24-or-0-0-7392]), and can predict the early treatment response of patients with NPC ([@b28-or-0-0-7392],[@b29-or-0-0-7392]).

PET/MR, a new medical imaging tool, combines the metabolic information of PET with the anatomical detail of MR, thus exhibiting good potential for clinical application ([@b30-or-0-0-7392]). There are two types of PET/MR systems: Sequential PET/MR, in which PET and MR data are acquired sequentially, either in a single room or using a tri-modality PET/CT-MRI system, and simultaneous PET/MR, in which PET and MR are integrated systems ([@b30-or-0-0-7392],[@b31-or-0-0-7392]). Several previous studies have investigated the diagnostic performance of PET/MR compared with PET/CT in head and neck cancer ([@b32-or-0-0-7392]--[@b38-or-0-0-7392]). Certain previous studies examined the clinical potential of PET/MR in NPC using simultaneous PET/MR, and no significant correlation between SUV and ADC in NPC was found by conventional mono-exponential DWI ([@b39-or-0-0-7392],[@b40-or-0-0-7392]). However, the feasibility of a routine application of PET/CT-MRI and the correlation between the IVIM parameters and SUV need to be further explored in NPC. Therefore, the aim of the present study was to assess the performance of PET/MR for the visualization and characterization of lesions and to further explore the correlation between SUV and ADC value, between SUV and D value, between SUV and D\* value, and between SUV and f value using sequential PET/MR in NPC.

Materials and methods
=====================

### Patients

The present study was approved by the Ethics Committee of The First Affiliated Hospital of Jinan University, and written informed consent was obtained from each participant. Inclusion criteria were as follows: All patients were diagnosed with NPC using histology, all underwent whole body ^18^F-FDG PET/CT, and all patients were examined with regular head and neck using a PET/CT-MRI system, and none received anti-tumor treatment before the PET/CT-MRI scan. Exclusion criteria were the following: Patients under 18 years of age, patients with claustrophobia and patients with MRI-incompatible medical devices, including cardiac pacemakers, cochlear implants and insulin pumps.

Between June 2015 and October 2017, 35 patients (7 women and 28 men; age, 50.4±11.7 years; age range, 24--77 years) were included. All patients presented non-keratinizing undifferentiated carcinoma. There were two patients at stage T1, four at T2, 14 at T3 and 15 at T4 primary tumors ([@b41-or-0-0-7392]). Nodal metastases and distant metastases were found in eight and 31 patients, respectively. All of the patients underwent additional multiple b-value DWI scans. However, two patients were excluded from further evaluation of the correlation between the SUV and ADC, and D\*, D and f values, because of image distortions in the DW images.

### Imaging modalities

All of the patients underwent a tri-modality PET/CT-MRI (full ring; time-of-flight Discovery PET/CT 690; 3T Discovery MR 750; GE Healthcare) comprising a sequential whole-body ^18^F-FDG PET/CT and a regular head and neck MRI. The patients were positioned on a dedicated shuttle board, facilitating their transport from the PET/CT to the MRI system without movement.

### PET/CT imaging

The patients fasted for at \>6 h before scanning and their blood glucose levels were measured immediately before the tracer injection. The patients were intravenously administered with ^18^F-FDG with an activity range of 0.08--0.10 mCi/kg body weight, and the data acquisition was performed after an uptake time of 50--70 min. The data acquisition was performed from the skull base to the mid-thigh, which were used for both the PET and CT modalities. The CT data were acquired with an automatic dose modulation at 120 kV, a range of 80--160 mA, a 512×512 image matrix, a field of view (FOV) of 50 cm, a noise index of 30, reconstructed slice thickness of 3.75 mm, and a slice interval of 3.27 mm. The PET protocol encompassed seven bed positions with a scan duration of 120 sec per bed position. The PET data was acquired in 3D time-of-flight mode using the adaptive statistical iterative reconstruction ([@b42-or-0-0-7392]) with an axial FOV of 70 cm, reconstructed slice thickness of 3.27 mm, a slice interval of 3.75 mm and a 192×192 image matrix. The attenuation correction was based on the whole-body CT.

### MRI

After PET/CT procedure, the patients were transferred to the MRI via a dedicated shuttle board. The MRI scans were acquired using the dedicated RF-covered nasopharynx coil. No contrast medium was applied during MRI. The imaging acquisition parameters for the applied MR sequences are presented in [Table I](#tI-or-0-0-7392){ref-type="table"}.

### Image analysis

All the images were analyzed by two investigators who evaluated both data sets. One investigator was an experienced nuclear medicine physician with 4 years of experience in MRI, and the second was a radiologist with additional experience in PET/CT. The PET, CT, and MRI data were sent to a dedicated review workstation (GE Advantage workstation, version 4.6; GE Healthcare Life Sciences) that allowed the simultaneous review of PET, CT and MR images side by side or in fused/overlay mode (PET/CT, T1w PET/MR and T2w PET/MR imaging).

### Visualization and characterization of lesions

Each PET examination was evaluated for the presence of PET-positive lesions within the body area that was covered by the head and neck MR imaging. NPC cases were considered PET-positive primary tumors if their maximum standardized uptake value (SUVmax) was markedly higher than the surrounding background activity. Cervical lymph node metastases were defined based on both functional and morphological criteria. The functional criteria used for the PET compound were: i) Visually detectable metabolic activity higher than normality; or ii) asymmetric metabolic activity greater than that of normal-appearing lymph nodes at the same level in the contralateral neck ([@b43-or-0-0-7392]). The morphological criteria for lymph node metastases on CT and MRI included ([@b44-or-0-0-7392]): i) A shortest axial diameter of \>5 mm in the retropharyngeal region and \>10 mm in other regions of the neck; ii) any nodes with necrosis or extracapsular spread; and iii) a group with \>2 nodes with a shortest axial diameter of \~5 mm in the retropharyngeal region and \~10 mm in other regions of the neck.

### Image quality

A 3-point scale was used for the assessment of image quality: i) 1=substantial artefacts with insufficient image quality for further assessment; ii) 2=mild artefacts with sufficient image quality for lesion assessment; and iii) 3=absence of relevant artefacts.

### Lesion conspicuity

Lesion conspicuity was graded on a 4-point scale according to the lesion delineation: i) 1, not detectable or poorly delineated (less than 25% of lesion borders definable); ii) 2, moderately delineated lesion borders (25--50% of borders definable); iii) 3, well delineated lesion borders (50--75% of borders definable); and iv) 4, excellently delineated (\>75% of lesion borders definable).

### Diagnostic confidence

To identify whether CT imaging and MR imaging can increase the diagnostic confidence for PET-positive primary tumors when characterizing tumor lesions, three scores were assigned: A grade of 1 indicated that MR imaging provided more relevant information than CT imaging, including infiltration of the adjacent structures such as the skull-base bone and prevertebral muscle. A grade of −1 indicated that CT imaging provided more information than MR imaging, including subtle bone destruction not visible on MR imaging. A grade of 0 indicated that both CT imaging and MR imaging provided the same information.

### SUV, ADC, and D\*, D and f values measurements

Using the dedicated review workstation (GE Advantage workstation; version 4.6; GE Healthcare Life Sciences), SUV of each voxel was calculated according to the following equation:
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The SUVmax and mean SUV (SUVmean) were calculated on the basis of activity values in regions of interest manually placed on the area of the tumor containing the highest-SUV pixel. The margin of the tumor was determined by visual inspection.

Subsequently, each investigator measured the IVIM parameters (D\*, D and f values) using the standard software on the workstation. The bi-exponential model from an IVIM sequence was expressed using the following equation, as described by Le *et al* ([@b45-or-0-0-7392]): Sb/S0=(1-f) exp (-b D) + f exp \[-b (D\* + D)\]. Where Sb is the signal intensity with diffusion gradient b; S0 is the signal intensity for a b value of 0 s/mm^2^; D is the true diffusion coefficient as reflected by pure molecular diffusion; f is the fractional perfusion related to microcirculation; and D\* is the pseudo-diffusion coefficient related to perfusion.

In addition, each investigator extracted the DW image with b values of 0 and 1,000 s/mm^2^ to calculate the ADC using a mono-exponential model with the following equation: Sb/S0=exp (-b ADC).

The regions of interest were manually drawn to delineate the borders of the primary tumor, in order to cover as much of the tumor as possible on each slice of the axial DW images that corresponded to the high-signal area on T2-weighted imaging with fat suppression, and avoiding apparent cystic changes, necrosis and adjacent anatomic structures ([Fig. 1](#f1-or-0-0-7392){ref-type="fig"}). The IVIM parameters obtained for each tumor were calculated on a pixel-by-pixel basis and expressed as the mean values of all pixels within the volume of interest. The minimum ADC (ADCmin) and mean ADC (ADCmean) were calculated for all primary tumors, with the ADCmin defined as the lowest ADC value within the whole tumor on the ADC map. Therefore, for each primary tumor, the ADCmean was defined as the mean value of all the tumor pixels on the ADC map.

### Statistical analysis

The data are presented as the mean ± SD. The differences between image quality and lesion conspicuity in PET/CT, T1w PET/MR, and T2w PET/MR imaging were analyzed using Friedman M test. The Nemenyi post hoc test was used to further evaluate the differences between two methods. The inter-observer agreement for the ADC, D\*, D and f values was evaluated using intraclass correlation coefficients (ICC). Pearson\'s correlation coefficient analysis was used to evaluate the correlation between the ADC (ADCmin and ADCmean), D\*, D and f values and the SUV (SUVmax and SUVmean). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Lesion detection

A total of 99 PET-positive lesions were evaluated, including 35 primary tumors and 64 lymph nodes. Among the 64 lymph nodes, there were 25 in the retropharyngeal space and 39 in other regions of the neck. All of the lesions had increased ^18^F-FDG uptake and all of the primary tumors could be detected by PET/CT, T1w PET/MR, and T2w PET/MR imaging. For the lymph nodes, PET/CT and T1w PET/MR imaging detected 61 lymph nodes, and the three other retropharyngeal lymph nodes were not detected by either PET/CT or T1w PET/MR imaging. However, T2w PET/MR imaging detected all of the lymph nodes. T2w PET/MR imaging is presented in [Fig. 2](#f2-or-0-0-7392){ref-type="fig"}.

### Image quality

No statistically significant differences were found between the artefact grading, an indicator of image quality, in T1w PET/MR, T2w PET/MR imaging and PET/CT ([Tables II](#tII-or-0-0-7392){ref-type="table"} and [III](#tIII-or-0-0-7392){ref-type="table"}). The artefacts did not originate in the nasopharynx but in the oral cavity, and these artefacts were caused by dental implants and, in one case, by eyeball motion. All of the dental implant artefacts were found in T1w PET/MR, T2w PET/MR and PET/CT, whereas the eyeball motion artefacts were found only in T2w PET/MR imaging ([Table II](#tII-or-0-0-7392){ref-type="table"}).

### Correlations between the SUV and ADC, and D, D\* and f values

There was no correlation between the ADC (ADCmin and ADCmean), D, D\* and f values and the SUV (SUVmax and SUVmean) for the primary tumors ([Table IV](#tIV-or-0-0-7392){ref-type="table"}; [Figs. 3](#f3-or-0-0-7392){ref-type="fig"} and [4](#f4-or-0-0-7392){ref-type="fig"}).

### Lesion conspicuity

Regarding the conspicuity of the primary tumors and lymph nodes, there were significant differences between PET/CT, T1w PET/MR imaging and T2w PET/MR imaging ([Tables III](#tIII-or-0-0-7392){ref-type="table"} and [V](#tV-or-0-0-7392){ref-type="table"}). Further comparison indicated that T1w PET/MR imaging and T2w PET/MR imaging were significantly more efficient than PET/CT in primary tumors (both P\<0.01) and in lymph nodes (both P\<0.01; [Fig. 5](#f5-or-0-0-7392){ref-type="fig"}). T2w PET/MR imaging was more efficient than T1w PET/MR imaging in primary tumors and in lymph nodes (data not shown).

### Diagnostic confidence

Regarding primary tumors characterization, T1w PET/MR imaging was considered superior to PET/CT in 71.4% of cases, equal to PET/CT in 22.9% of cases, and inferior to PET/CT in 5.7% of cases. T2w PET/MR imaging was considered superior to PET/CT in 77.2% of cases ([Fig. 6](#f6-or-0-0-7392){ref-type="fig"}), equal to PET/CT in 17.1% of cases, and inferior to PET/CT in 5.7% of cases.

### SUV and ADC, and D\*, D and f values

The mean SUVmax and mean SUVmean values of all primary tumors were 12.6±4.9 (range 4.7--25.9) and 7.6±3.0 (range 2.6--16.5), respectively (data not shown). The means of the ADCmin, ADCmean, D\*, D and f values of all primary tumors were (7.78±1.25) ×10^−4^ mm^2^/s, (8.14±1.23) ×10^−4^ mm^2^/s, (5.44±2.01) ×10^−3^ mm^2^/s, (5.13±0.59) ×10^−4^ mm^2^/s and 28.68±6.40%, respectively.

### Inter-observer agreement

The ICCs (95% CI) of the inter-observer reproducibility for the measurements of the ADC, D\*, D and f values were 0.990 (0.983 to 0.994), 0.970 (0.940 to 0.985), 0.898 (0.801 to 0.948) and 0.969 (0.938 to 0.985), respectively, which suggested good inter-observer reproducibility and consistency.

Discussion
==========

PET/CT has high sensitivity in diagnosing NPC, and MR shows a sensitivity of \~100% ([@b46-or-0-0-7392]). In the present study, a total of 35 NPC primary tumors had increased ^18^F-FDG uptake and were detected on PET/CT and PET/MR, in line with a previous study ([@b39-or-0-0-7392]). However, Chen *et al* ([@b47-or-0-0-7392]) reported only 15 patients with FDG uptake out of 20 newly-diagnosed patients with NPC. This difference may be due to the pathological subtype of NPC investigated in the present study. In fact, the NPC examined was a non-keratinizing undifferentiated carcinoma of a relatively simple type, which resulted in high ^18^F-FDG uptake from the NPC. In terms of tumor conspicuity, PET/CT did not efficiently delineated the tumor borders, whereas 85.7% of lesion borders could be efficiently delineated by T2w PET/MR imaging. These present results showed that tumor conspicuity was significantly higher in T2w PET/MR imaging than in PET/CT. However, the quality of PET/MR imaging was enough to delineate lesions relative to the surrounding soft tissue. Considering the potential infiltration of NPC into the adjacent structures, such as the prevertebral muscle, internal carotid artery and skull base, as well as intracranial spread, PET/MR showed more reliable determination of tumor tissue.

FDG PET/CT has a growing role in the diagnosis and management of NPC. The clinical value of ^18^F-FDG PET/CT for evaluating the T stage of patients with NPC is limited by the spillover effect of ^18^F-FDG, low spatial resolution and imaging misregistration ([@b2-or-0-0-7392],[@b48-or-0-0-7392]). The present study showed that the tumor conspicuity and the diagnostic confidence of PET/MR were significantly higher than those of PET/CT. These parameters are of particular importance because the T classification of NPC depends on the infiltration of adjacent structures. A previous study also showed that ^18^F-FDG PET/MR is more accurate than head and neck MRI and PET/CT in terms of tumor staging ([@b39-or-0-0-7392]).

NPC is prone to cervical lymph node metastasis and the retropharyngeal lymph nodes are considered first echelon nodes ([@b1-or-0-0-7392]). Accurate detection of lymph node metastasis is important for N staging ([@b41-or-0-0-7392]) in NPC. In the present study, a total of 64 suspicious metastatic lymph nodes were detected by T2w PET/MR. However, PET/CT and T1w PET/MR imaging detected 61 lymph nodes, apart from three retropharyngeal lymph nodes. Since the three retropharyngeal lymph nodes were merging with the primary tumors, PET/CT and T1w PET/MR imaging could not separate the retropharyngeal lymph nodes from the primary tumors, while a clear distinction between the primary tumor and the attached retropharyngeal lymph nodes was achieved using T2w PET/MR imaging.

Considering the conspicuity of the lymph nodes, the present results showed that T1w PET/MR imaging and T2w PET/MR imaging were more efficient than PET/CT. However, a previous study reported no significant difference between contrast-enhanced PET/CT, T2w PET/MR imaging, and contrast-enhanced PET/MR in the detection and conspicuity of cervical lymph nodes ([@b33-or-0-0-7392]). This discrepancy may be due to the fact that 42.1% (32/76) of the lymph nodes were retropharyngeal in the present study, and CT without contrast medium does not define the margins in retropharyngeal lymph nodes. Since MR has high soft tissue contrast, especially T2w MR imaging with fat suppression, it is efficient to detect and to delineate lymph nodes, and this modality is also adequate for the detection of cystic or necrotic lymph nodes.

Intensity-modulated radiotherapy (IMRT) is the primary and preferred treatment method for NPC ([@b1-or-0-0-7392]), and the accurate delineation of target volumes and normal organs relies on clear lesion borders. CT, MR and MR/CT fusion imaging are the basic methods for delineating the target volumes, and PET/CT facilitates radiation therapy planning ([@b49-or-0-0-7392]). Moreover, in the present study, it was showed that T1w PET/MR imaging and T2w PET/MR imaging performed significantly better than PET/CT with respect of the conspicuity of the primary tumors and lymph nodes. PET/MR delineated more lesion borders, and it may be possible to determine and deliver the most appropriate radiation dose level to different parts of the target volume with IMRT. The volume of interest (VOI) of DWI and the VOI of FDG PET were not completely overlapping and the volume defined by cluster analysis might be useful for dose painting ([@b40-or-0-0-7392]), which has been applied in radiotherapy for NPC.

Whether SUV and ADC calculated by conventional mono-exponential DWI are statistically correlated or independent biomarkers in tumors has been investigated by numerous previous studies ([@b8-or-0-0-7392]--[@b19-or-0-0-7392],[@b40-or-0-0-7392]). Cao *et al* ([@b40-or-0-0-7392]) reported that no significant correlation between SUV and ADC was observed in NPC. The present results were concordant with these previous findings, indicating that these two biomarkers are independent in NPC; the present results are also in line with previous studies in HNSCC ([@b8-or-0-0-7392],[@b17-or-0-0-7392],[@b19-or-0-0-7392]). However, Nakajo *et al* ([@b18-or-0-0-7392]) found a significant negative correlation between SUVmax and ADC~800~ in 26 patients with HNSCC, while Choi *et al* ([@b19-or-0-0-7392]) showed that the ADCratio (ADC~2000~/ADC~1000~) was significantly and positively correlated to SUV. There were some differences in these previous studies in the interval times between PET and MR scans, which ranged between 3 days and 2 weeks. In the present study, PET and MR scanning were performed on the same day using sequential PET/MR. Therefore, the correlation between SUV and ADC may be made more reliable by shortening the time interval between PET and MR analyses.

Traditional DWI via the conventional mono-exponential model cannot distinguish between true diffusion and microcirculatory perfusion ([@b27-or-0-0-7392]). It has been confirmed that microcirculation of the blood or perfusion in capillary networks can substantially affect the measurement of ADC values ([@b21-or-0-0-7392]). According to the IVIM theory, D represents true molecular diffusion, while D\* is proportional to the average blood velocity and the mean capillary segment length ([@b50-or-0-0-7392]), which indicates that D\* is linked to vascularity and perfusion in tissues. The f value is another perfusion-related parameter corresponding to the fractional volume (percentage) of capillary blood flow ([@b27-or-0-0-7392]). Therefore, whether IVIM parameters (D\*, D and f values) had any significant correlation with SUV in NPC were investigated in the present, and IVIM showed the ability to separately quantitate the diffusion and perfusion effects.

The present preliminary results showed that there was no significant correlation between the SUV and D\*, D and f values. ADC represents the total diffusion value and D represents true diffusion, and there was no correlation between these two factors with SUV regarding cellular glucose metabolism. Furthermore, no relationship was found between cellular glucose metabolism and cellular perfusion in the present study. The SUV and D, D\*, and f values are independent biomarkers in NPC. Although the possible correlation between SUV and ADC remains controversial, and there was no significant correlation between the SUV and D\*, D and f values in NPC, these parameters are all biomarkers that may potentially predict early treatment responses. Additional work should investigate the correlation between the SUV and D\*, D and f values in other tumors.

Notably, the present study had several limitations. No contrast medium was applied during MRI and CT, therefore, it was not possible to analyze the lesion characterization in cePET/CT and cePET/MR imaging. In addition, the PET/MR comprised only a head and neck protocol, so no other body were analyzed by the MR imaging to evaluate distant metastasis. Moreover, the patient cohort was relatively small, and all NPC patients presented undifferentiated carcinomas. Therefore, a larger sample size should be used for further investigation and the correlation between the SUV and ADC, D, D\* and f values of differentiated carcinomas should be further analyzed. Further studies are required to analyze whether the biomarkers of NPC may show a correlation with tumor differentiation.

The present study suggested that PET/MR was more efficient in the visualization and characterization of NPC compared with PET/CT. As a result, PET/MR showed high lesion detection and good image quality. Additionally, PET/MR offered higher lesion conspicuity and diagnostic confidence for NPC, which may facilitate radiotherapy planning and tumor classification. However, no correlations were identified between the SUV assessed by ^18^F-FDG PET/CT, and the ADC, D, D\* and f values determined by IVIM with multiple b values in NPC. The present findings suggested that SUV and ADC, D, D\* and f values are independent biomarkers in NPC, and they may provide different information, thus facilitating a correct diagnosis.
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![A 62-year-old male patient with NPC. (A) Axial T2w imaging and (B) axial DW imaging showing a region of interest around the margin of NPC. (C) ADC, (D) D\*, (E) D and (F) f maps. The ADC, D\*, D, and f values were 8.43×10^−4^ mm^2^/s, 4.27×10^−3^ mm^2^/s, 5.59×10^−4^ mm^2^/s, and 0.291, respectively. NPC, nasopharyngeal carcinoma; ADC, apparent diffusion coefficient; D, true diffusion coefficient; D\*, pseudo-diffusion coefficient.](or-43-01-0177-g01){#f1-or-0-0-7392}

![A 58-year-old male patient with NPC. The left retropharyngeal node was merged with the primary tumor. (A) PET/CT imaging. (B) PET and (C) CT did not separate retropharyngeal nodes from the adjacent primary tumor. (D) T1w PET/MR imaging. (E) T1w imaging. (F) T2w imaging was able to separate the left retropharyngeal node from the primary tumor in the adjacent posterolateral nasopharynx (indicated by an arrow). PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted; NPC, nasopharyngeal carcinoma.](or-43-01-0177-g02){#f2-or-0-0-7392}

![Correlation analysis. Scatter plots of the correlation between (A) SUVmax and ADCmin, (B) SUVmax and D\*, (C) SUVmax and D, and (D) SUVmax and f%. No statistically significant correlation was found. SUV, standardized uptake values; ADC, apparent diffusion coefficient; D, true diffusion coefficient; D\*, pseudo-diffusion coefficient.](or-43-01-0177-g03){#f3-or-0-0-7392}

![Correlation analysis. Scatter plots of the correlation between (A) SUVmean and ADCmean, (B) SUVmean and D\*, (C) SUVmean and D, and (D) SUVmean and f%. No statistically significant correlation was found between the SUVmean and ADCmean, D\*, D and f values. SUV, standardized uptake values; ADC, apparent diffusion coefficient; D, true diffusion coefficient; D\*, pseudo-diffusion coefficient.](or-43-01-0177-g04){#f4-or-0-0-7392}

![A 38-year-old male patient suffering from prevertebral muscle invasion of NPC. Prevertebral muscle invasion of NPC is indicated by an arrow. (A) Image artefacts caused by dental implants that affected the PET/CT. (B) PET imaging. (C) CT scan. (D) PET/MR and (E) MR were not affected by artefacts. (F) T2w imaging could delineate the margin of the retropharyngeal lymph node, indicated by an arrowhead. PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted.](or-43-01-0177-g05){#f5-or-0-0-7392}

![Infiltration of the adjacent structures by PET/CT and PET/MR in a 39-year-old male patient. (A) PET, (B) PET/CT and (C) T1w PET/MR imaging showed the high uptake of the lesions. However, (D) CT showed no destruction of the occipital bone. (E) MR revealed marrow infiltration (indicated by an arrow) with hypointense areas on (F) T1w imaging and hyperintense areas on fat suppression T2w imaging. MR showed that the right internal carotid artery was surrounded by lesions (indicated by an arrowhead). PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted.](or-43-01-0177-g06){#f6-or-0-0-7392}

###### 

Acquisition parameters for the applied MR sequences.

                        FSE T1WI   FRFSE T2WI   SS-EPI DWI                 
  --------------------- ---------- ------------ ------------ ------------- --------------------------------------------------
  TR/TE, ms             466/14.1   350/13.8     3,877/81.3   3,023/108.2   3,000/80
  FOV, cm               20×20      26×26        20×20        26×26         24×24
  Thickness, mm         3.5        4.0          3.5          4.0           3.5
  Slice space, mm       0.5        1.5          0.5          0.5           0.5
  Matrix                288×224    320×256      288×256      288×256       128×128
  Acceleration factor   2          2            2            2             2
  Bandwidth, kHz        31.2       31.2         41.7         41.7          250
  Flip angle, °         111        111          111          111           90
  B Values, s/mm^2^     NA         NA           NA           NA            0, 50, 200, 500, 800, 1,000, 1,500, 2,000, 3,000
  NEX                   2          1            3            3             1, 1, 1, 1, 2, 2, 4, 4, 6

FSE T1WI, fast spin-echo T1-weighted imaging; FRFSE T2WI, fast recovery fast spin-echo T2-weighted imaging; SS-EPI DWI, single-shot echo planar diffusion-weighted imaging; TR, repetition time; TE, echo time; FOV, field of view; NEX, number of excitations; NA, not applicable.

###### 

Artefact graded for the three techniques.

  Grade         PET/CT (%)   T1w PET/MR (%)   T2w PET/MR (%)
  ------------- ------------ ---------------- ----------------
  No            88.6         88.6             80.0
  Mild            8.6        11.4             20.0
  Substantial     2.8        0                0

PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted.

###### 

Image quality and lesion conspicuity in the three imaging techniques.

  Parameter examined                 PET/CT     T1w PET/MR   T2w PET/MR   P-value
  ---------------------------------- ---------- ------------ ------------ ---------
  Image quality, median (range)      3 (1--3)   3 (2--3)     3 (2--3)     0.174
  Lesion conspicuity                                                      
    Primary tumors, median (range)   2 (1--3)   3 (2--4)     4 (3--4)     \<0.001
    Lymph nodes, median (range)      3 (1--4)   4 (1--4)     4 (3--4)     \<0.01

PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted.

###### 

Correlations between the SUV and ADC, and D, D\* and f values.

  Correlation           r        P-value
  --------------------- -------- ---------
  SUVmax and ADCmin     −0.025   0.892
  SUVmax and D          −0.107   0.553
  SUVmax and D\*        −0.060   0.741
  SUVmax and f          −0.159   0.378
  SUVmean and ADCmean   0.014    0.936
  SUVmean and D         −0.102   0.573
  SUVmean and D\*       −0.057   0.753
  SUVmean and f         −0.186   0.300

SUV, standardized uptake values; ADC, apparent diffusion coefficient; D, true diffusion coefficient; D\*, pseudo-diffusion coefficient.

###### 

Lesion conspicuity in the three imaging techniques.

              Primary tumors   Lymph nodes                         
  ----------- ---------------- ------------- ------ ------ ------- ------
  Poor        28.6             0             0      15.6     4.7   0
  Moderate    48.6             14.3          0      15.6     3.1   0
  Well        22.8             40.0          14.3   20.3   10.9    1.6
  Excellent   0                45.7          85.7   48.5   81.3    98.4

PET, positron emission tomography; MR, magnetic resonance imaging; CT, computed tomography; T1w, T1 weighted.
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